See also this year's filing and all EDGAR filings for this company.
PDF Report 0001081938_2023_CANNAPHARMARX_INC.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 4.393937403352601e-08, 'aggregate_val': 22758632, 'exp_sum': 22758631, 'exp_to_value': {'LiabilitiesCurrent': 17165154, 'LiabilitiesNoncurrent': 0, 'remainder_Liabilities': 5593477}} |
Graph
Absolute values for 0001081938, CANNAPHARMARX INC.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 100,014 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 107,780 |
3 | remainder_Assets | 5,206,382 |
4 | LiabilitiesCurrent | 17,165,154 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 5,593,478 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 2,226,668 |
9 | ResearchAndDevelopmentExpense | 0 |
10 | remainder_Expenses | 2,985,141 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | -3,319,211 |
13 | remainder_ComprehensiveNetIncome | 612,335 |
yvar | yval | |
---|---|---|
0 | Assets | 5,414,176 |
1 | Liabilities | 22,758,632 |
2 | Expenses | 5,211,809 |
3 | Revenues | 0 |
4 | StockholdersEquity | -17,344,456 |
5 | NetIncome | -8,531,020 |
6 | ComprehensiveNetIncome | -8,224,852 |
7 | BaseVar | 18,658,082 |
8 | EconomicCapitalRatio | -2.70 |